Serum and vitreous VEGF levels was significantly lower in patients on oral therapy, in those with well controlled glycemia, and in those with early-stage retinopathy. Administration of anti-VEGF had a good effect in reducing the progression of proliferative diabetic retinopathy.
No takes yet. Share an insight, caveat, or question.
Panahi et al. (2012) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: